- Home
- XYF vs AMLX Comparison
XYF vs AMLX Comparison
Compare XYF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYF
- AMLX
- Stock Information
- Founded
- XYF 2014
- AMLX 2014
- Country
- XYF China
- AMLX United States
- Employees
- XYF N/A
- AMLX N/A
- Industry
- XYF Finance: Consumer Services
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- XYF Finance
- AMLX Health Care
- Exchange
- XYF Nasdaq
- AMLX Nasdaq
- Market Cap
- XYF 708.7M
- AMLX 749.9M
- IPO Year
- XYF 2018
- AMLX 2022
- Fundamental
- Price
- XYF $14.20
- AMLX $11.89
- Analyst Decision
- XYF
- AMLX Strong Buy
- Analyst Count
- XYF 0
- AMLX 7
- Target Price
- XYF N/A
- AMLX $12.29
- AVG Volume (30 Days)
- XYF 449.3K
- AMLX 1.8M
- Earning Date
- XYF 08-18-2025
- AMLX 11-06-2025
- Dividend Yield
- XYF 3.94%
- AMLX N/A
- EPS Growth
- XYF 41.77
- AMLX N/A
- EPS
- XYF 5.32
- AMLX N/A
- Revenue
- XYF $1,047,188,328.00
- AMLX N/A
- Revenue This Year
- XYF N/A
- AMLX N/A
- Revenue Next Year
- XYF N/A
- AMLX N/A
- P/E Ratio
- XYF $2.58
- AMLX N/A
- Revenue Growth
- XYF 45.10
- AMLX N/A
- 52 Week Low
- XYF $4.53
- AMLX $2.37
- 52 Week High
- XYF $20.36
- AMLX $12.25
- Technical
- Relative Strength Index (RSI)
- XYF 45.65
- AMLX 80.23
- Support Level
- XYF $13.30
- AMLX $9.15
- Resistance Level
- XYF $14.60
- AMLX $12.25
- Average True Range (ATR)
- XYF 0.71
- AMLX 0.56
- MACD
- XYF -0.03
- AMLX 0.23
- Stochastic Oscillator
- XYF 29.03
- AMLX 90.50
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.